Literature DB >> 28867852

Risk and Emotion Among Healthy Volunteers in Clinical Trials.

Marci D Cottingham1, Jill A Fisher2.   

Abstract

Theorized as objective or constructed, risk is recognized as unequally distributed across social hierarchies. Yet the process by which social forces shape risk and risk emotions remains unknown. The pharmaceutical industry depends on healthy individuals to voluntarily test early-stage, investigational drugs in exchange for financial compensation. Emblematic of risk in late modernity, Phase I testing is a rich site for examining how class and race shape configurations of emotion and risk. Using interview data from 178 healthy trial participants, this article examines emotion and risk as mutually constituting processes linked to biographical context and social structure. Biographical events like economic insecurity and incarceration influence how risk is felt by providing comparative experiences of felt risk and felt benefits. Such events, in turn, are structured by class-based and racial inequalities, linking class and race positions to primary emotional experiences of risk.

Entities:  

Keywords:  class; emotion; gender; pharmaceutical industry; race; risk

Year:  2016        PMID: 28867852      PMCID: PMC5580945          DOI: 10.1177/0190272516657655

Source DB:  PubMed          Journal:  Soc Psychol Q        ISSN: 0190-2725


  13 in total

1.  Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality.

Authors:  Paul Slovic; Melissa L Finucane; Ellen Peters; Donald G MacGregor
Journal:  Risk Anal       Date:  2004-04       Impact factor: 4.000

2.  Challenging assumptions about minority participation in US clinical research.

Authors:  Jill A Fisher; Corey A Kalbaugh
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

3.  French drug trial had three major failings, says initial report.

Authors:  Nigel Hawkes
Journal:  BMJ       Date:  2016-02-08

4.  Injury to research volunteers--the clinical-research nightmare.

Authors:  Alastair J J Wood; Janet Darbyshire
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

5.  Current directions in risk research: new developments in psychology and sociology.

Authors:  Peter Taylor-Gooby; Jens O Zinn
Journal:  Risk Anal       Date:  2006-04       Impact factor: 4.000

6.  Expanding the frame of "voluntariness" in informed consent: structural coercion and the power of social and economic context.

Authors:  Jill A Fisher
Journal:  Kennedy Inst Ethics J       Date:  2013-12

7.  Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S. phase I studies.

Authors:  Heather B Edelblute; Jill A Fisher
Journal:  J Empir Res Hum Res Ethics       Date:  2015-01-20       Impact factor: 1.742

8.  Stopped hearts, amputated toes and NASA: contemporary legends among healthy volunteers in US phase I clinical trials.

Authors:  Jill A Fisher
Journal:  Sociol Health Illn       Date:  2015-01

9.  Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials.

Authors:  Jill A Fisher
Journal:  Sci Technol Human Values       Date:  2015-03-01

10.  'I'm still a hustler': entrepreneurial responses to precarity by participants in phase I clinical trials.

Authors:  Torin Monahan; Jill A Fisher
Journal:  Econ Soc       Date:  2016-01-06
View more
  13 in total

1.  Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation.

Authors:  Matt Lamkin; Carl Elliott
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

2.  Disadvantaged, Outnumbered, and Discouraged: Women's Experiences as Healthy Volunteers in U.S. Phase I Trials.

Authors:  Nupur Jain; Marci D Cottingham; Jill A Fisher
Journal:  Crit Public Health       Date:  2018-10-10

3.  Captive to the Clinic: Phase I Clinical Trials as Temporal Total Institutions.

Authors:  Quintin Williams; Jill A Fisher
Journal:  Sociol Inq       Date:  2018-04-20

4.  Gendered Logics of Biomedical Research: Women in U.S. Phase I Clinical Trials.

Authors:  Marci D Cottingham; Jill A Fisher
Journal:  Soc Probl       Date:  2020-10-11

5.  Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.

Authors:  Jill A Fisher; Lisa McManus; Megan M Wood; Marci D Cottingham; Julianne M Kalbaugh; Torin Monahan; Rebecca L Walker
Journal:  J Empir Res Hum Res Ethics       Date:  2018-10-08       Impact factor: 1.742

6.  Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials.

Authors:  Marci D Cottingham; Julianne M Kalbaugh; Teresa Swezey; Jill A Fisher
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

7.  Commentary on Zvonareva et al.: Exploring the many meanings of "professional" in research participation.

Authors:  Jill A Fisher
Journal:  Clin Trials       Date:  2019-10-05       Impact factor: 2.486

8.  From fantasy to reality: managing biomedical risk emotions in and through fictional media.

Authors:  Marci D Cottingham; Jill A Fisher
Journal:  Health Risk Soc       Date:  2017-07-11

9.  Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research.

Authors:  Rebecca L Walker; Marci D Cottingham; Jill A Fisher
Journal:  J Med Philos       Date:  2018-01-12

10.  Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.

Authors:  Jill A Fisher; Lisa McManus; Marci D Cottingham; Julianne M Kalbaugh; Megan M Wood; Torin Monahan; Rebecca L Walker
Journal:  PLoS Med       Date:  2018-11-20       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.